EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Predictors and prognostic stratification of bronchiolitis obliterans syndrome after pediatric allogeneic hematopoietic stem cell transplantation

Canran Wang, Guoyu Ding, Xiaoyue Zhang, Hongjuan Li, Yan Gu, Yan Han, Xue Li, Yuqi Zhao, Huidi Feng, Ziyun Lin, Hongmei Wang

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-07253-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2026. Verfasst von Canran Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bronchiolitis Obliterans Syndrome (BOS) following pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT) is associated with high morbidity and mortality, largely due to diagnostic delays and static prognostic assessments. This study aimed to validate the value of a strategy based on dynamic pulmonary function monitoring for early warning and prognostic stratification in the management of pediatric BOS.

Methods

This single-center, retrospective cohort study included 201 children who underwent allo-HSCT between January 2015 and December 2024, comprising 29 patients with BOS and 172 non-BOS controls. Independent risk factors for BOS were identified using multivariate Cox regression analysis. We evaluated the diagnostic performance of an "at-risk stage" warning signal based on the relative decline in Forced Expiratory Volume in 1 second (FEV1). In the longitudinal cohort of BOS patients, the independent predictive value of the FEV1 decline rate within the first 3 months post-diagnosis for progression-free survival (PFS) was investigated. The longitudinal trajectories of pulmonary function and high-resolution computed tomography (HRCT) imaging scores were also compared.

Results

The cumulative incidence of pediatric BOS at our center was 6.9%. Multivariate analysis identified grade III-IV acute graft-versus-host disease (aGVHD) (HR = 15.12), chronic GVHD (cGVHD) (HR = 6.94), dry cough (HR = 11.77), and an early post-transplant FEV1/FVC decline of ≥ 10% (HR = 8.70) as independent risk factors for BOS development. Using a relative FEV1 decline of ≥ 10% (termed BOS stage 0p) as an early warning signal advanced the diagnostic window by a mean of 176 days and demonstrated a high negative predictive value of 84.95%. For prognosis, a rapid FEV1 decline (≥ 25%) within the first 3 months post-diagnosis was a strong independent predictor for inferior PFS (adjusted HR = 30.68, 95% CI: 3.39-277.79, P = 0.002), independent of the NIH severity grade at diagnosis. Furthermore, a significant "radio-functional discordance" was revealed, where HRCT structural damage scores continued to worsen even as pulmonary function stabilized in some patients (P < 0.001).

Conclusion

This study confirms that a strategy based on dynamic pulmonary function monitoring effectively addresses key challenges in pediatric BOS management. Monitoring the relative decline in FEV1 serves as a sensitive early warning tool, significantly advancing the diagnostic window. Moreover, assessing the early FEV1 decline rate post-diagnosis provides a powerful dynamic tool for achieving precise prognostic stratification and guiding individualized treatment escalation. The evaluation of BOS treatment response should concurrently address functional improvement and potential underlying structural deterioration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationBronchiolitis Obliterans SyndromeBronchiolitis ObliteransHumansRetrospective StudiesFemaleChildPrognosisMaleChild, PreschoolTransplantation, HomologousRisk FactorsAdolescentInfantTomography, X-Ray ComputedRespiratory Function Tests

Stichwörter der Autor:innen

Allogeneic Hematopoietic Stem Cell TransplantationBronchiolitis Obliterans SyndromeChildrenPrognosisPulmonary Function Test

Autor:innen und Institutionen

  • Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Department of Pediatric Hematology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, No. 16766, Jing Shi Road, Lixia District, Jinan, Shandong, 250014, China.
  • Department of Pediatric Hematology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, No. 16766, Jing Shi Road, Lixia District, Jinan, Shandong, 250014, China.…

Zitieren

APA

Wang, C., Ding, G., Zhang, X., Li, H., Gu, Y., Han, Y., Li, X., Zhao, Y., Feng, H., Lin, Z., & Wang, H. (2026). Predictors and prognostic stratification of bronchiolitis obliterans syndrome after pediatric allogeneic hematopoietic stem cell transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-026-07253-0

Vancouver

Wang C, Ding G, Zhang X, Li H, Gu Y, Han Y, et al. Predictors and prognostic stratification of bronchiolitis obliterans syndrome after pediatric allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2026. doi:10.1007/s00277-026-07253-0

BibTeX
@article{Wang2026,
  author = {Wang, Canran and Ding, Guoyu and Zhang, Xiaoyue and Li, Hongjuan and Gu, Yan and Han, Yan and Li, Xue and Zhao, Yuqi and Feng, Huidi and Lin, Ziyun and Wang, Hongmei},
  title = {Predictors and prognostic stratification of bronchiolitis obliterans syndrome after pediatric allogeneic hematopoietic stem cell transplantation},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07253-0}
}
Kostenlos starten →